Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.69 -0.01 (-0.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Operating Margin (2018 - 2026)

Updated

Arcturus Therapeutics Holdings' Operating Margin came in at -863.30% for Q2 2026, down 822.25 percentage points from -41.04% a year earlier but up 540.44 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Operating Margin (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Arcturus Therapeutics Holdings reported Operating Margin of -348.33%, down 288.91 percentage points year-over-year; for FY2025, it came in at -92.96%, down 30.15 percentage points from FY2024.

  • Operating Margin has declined in each of the last three years, though with a five-year change of +656.84 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -62.81% in FY2024 (-15.93 pp), -46.89% in FY2023 (-52.80 pp), 5.91% in FY2022 (+1647.24 pp) and -1641.33% in FY2021 (-891.52 pp).
  • The five-year range for quarterly Operating Margin is -2208.49% (Q3 2021) to 75.77% (Q4 2022).
  • Year-over-year, Operating Margin has declined for four consecutive quarters, with an average year-over-year change of -321.75 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q2 2022 (a gain of 2603.13 percentage points), and the weakest in Q1 2026 (a drop of 1346.47 percentage points).
  • Business Quant data shows ARCT's Operating Margin at -1403.74% (Q1 2026), -435.06% (Q4 2025) and -96.27% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Arcturus Therapeutics Holdings 389.40 Mn -424.73 Mn - -863.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -863.30%
Mar 31, 2026 -1,403.74%
Dec 31, 2025 -435.06%
Sep 30, 2025 -96.27%
Jun 30, 2025 -41.04%
Mar 31, 2025 -57.27%
Dec 31, 2024 -146.68%
Sep 30, 2024 -25.76%
Jun 30, 2024 -42.37%
Mar 31, 2024 -80.01%
Dec 31, 2023 -59.22%
Sep 30, 2023 -42.79%
Jun 30, 2023 -526.42%
Mar 31, 2023 18.38%
Dec 31, 2022 75.77%
Sep 30, 2022 -275.32%
Jun 30, 2022 -81.53%
Mar 31, 2022 -960.70%
Dec 31, 2021 -649.72%
Sep 30, 2021 -2,208.49%
API Access

Arcturus Therapeutics Holdings Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEY